Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Nucleozin

SKU: orb1299914

Description

Nucleozin is a small molecule inhibitor that targets the influenza A nucleoprotein (NP), an essential RNA-binding protein for viral replication. It has demonstrated antiviral activity in both cell-based assays and animal models, making it a valuable research tool for studying influenza pathogenesis and developing novel therapeutics.

Research Area

Infectious Disease & Virology

Images & Validation

Key Properties

CAS Number341001-38-5
MW426.85
Purity98.00% (May vary between batches)
FormulaC21H19ClN4O4
SMILESCc1onc(c1C(=O)N1CCN(CC1)c1ccc(cc1Cl)[N+]([O-])=O)-c1ccccc1
TargetInfluenza Virus
SolubilityDMSO:28.66 mg/mL (67.14 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.69 mM)

Bioactivity

In Vivo
Nucleozin, that triggers the aggregation of NP and inhibits its nuclear accumulation. Nucleozin impeded influenza A virus replication in vitro with a nanomolar median effective concentration (EC(50)) and protected mice challenged with lethal doses of avian influenza A H5N1. Viral NP is a valid target for the development of small-molecule therapies.
In Vitro
Nucleozin blocked the cytoplasmic trafficking of ribonucleoproteins (RNPs) that had undergone nuclear export, promoting the formation of large perinuclear aggregates of RNPs along with cellular Rab11. This effect led to the production of much reduced amounts of often markedly smaller virus particles. The primary target of nucleozin is the viral RNP. IAV replication can be effectively inhibited by blocking cytoplasmic trafficking of the viral genome.
Cell Research
For live imaging, cells were grown in chambered glass bottom dishes and maintained at 37°C in L-15 CO2-independent medium (Gibco) during analysis. Cells were transfected with GFP-NP and infected with PR8 12 h later. For nucleozin treatment, images were acquired for 5 min and then nucleozin was added to a final concentration of 2 μM before imaging for around 20 to 30 min . Images were acquired at 0.25 or 0.71 frame/s and processed with ImageJ.

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

accumulation, Inhibitor, InfluenzaVirus, Influenza virus, Influenza Virus, inhibit, infection, nuclear, Nucleozin, nucleoprotein, replication, virus, viral

Similar Products

  • Nucleozin [orb1225256]

    >98% (HPLC)

    341001-38-5

    426.853

    C21H19ClN4O4

    10 mg, 25 mg, 50 mg, 100 mg, 2 mg, 5 mg, 200 mg, 500 mg, 1 g
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

2 mg
$ 80.00
5 mg
$ 100.00
1 ml x 10 mM (in DMSO)
$ 110.00
10 mg
$ 130.00
25 mg
$ 220.00
50 mg
$ 330.00
100 mg
$ 440.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry